Long Term Debt - Newron Pharmaceuticals SpA (SIX:NWRN) - Alpha Spread

Newron Pharmaceuticals SpA
SIX:NWRN

Watchlist Manager
Newron Pharmaceuticals SpA Logo
Newron Pharmaceuticals SpA
SIX:NWRN
Watchlist
Price: 7.66 CHF -3.04%
Market Cap: 145.9m CHF
Have any thoughts about
Newron Pharmaceuticals SpA?
Write Note

Newron Pharmaceuticals SpA
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Newron Pharmaceuticals SpA
Long-Term Debt Peer Comparison

Comparables:
REC
P
PRL
FCM
SHE

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Newron Pharmaceuticals SpA
SIX:NWRN
Long-Term Debt
€26m
CAGR 3-Years
0%
CAGR 5-Years
191%
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Long-Term Debt
€1.4B
CAGR 3-Years
15%
CAGR 5-Years
17%
CAGR 10-Years
20%
P
Pierrel SpA
MIL:PRL
Long-Term Debt
€21.2m
CAGR 3-Years
30%
CAGR 5-Years
15%
CAGR 10-Years
5%
Friulchem SpA
MIL:FCM
Long-Term Debt
€7.8m
CAGR 3-Years
28%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Shedir Pharma Srl Unipersonale
MIL:SHE
Long-Term Debt
€4.6m
CAGR 3-Years
-28%
CAGR 5-Years
-15%
CAGR 10-Years
N/A

See Also

What is Newron Pharmaceuticals SpA's Long-Term Debt?
Long-Term Debt
26m EUR

Based on the financial report for Dec 31, 2023, Newron Pharmaceuticals SpA's Long-Term Debt amounts to 26m EUR.

What is Newron Pharmaceuticals SpA's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
191%

Over the last year, the Long-Term Debt growth was -43%.

Back to Top